BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. A novel risk score to stratify severity of Crohn's disease hospitalizations. Am J Gastroenterol. 2010;105:1799-1807. [PMID: 20216534 DOI: 10.1038/ajg.2010.105] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Kruger AJ, Hinton A, Afzali A. To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients. Inflamm Bowel Dis 2019;25:e74-6. [PMID: 30597020 DOI: 10.1093/ibd/izy391] [Reference Citation Analysis]
2 Luu M, Benzenine E, Doret M, Michiels C, Barkun A, Degand T, Quantin C, Bardou M. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION). American Journal of Gastroenterology 2018;113:1669-77. [DOI: 10.1038/s41395-018-0176-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 19.8] [Reference Citation Analysis]
3 Gajendran M, Umapathy C, Loganathan P, Hashash JG, Koutroubakis IE, Binion DG. Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA. Dig Dis Sci. 2016;61:389-399. [PMID: 26423080 DOI: 10.1007/s10620-015-3895-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
4 Kruger AJ, Aberra F, Black SM, Hinton A, Hanje J, Conteh LF, Michaels AJ, Krishna SG, Mumtaz K. A validated risk model for prediction of early readmission in patients with hepatic encephalopathy. Annals of Hepatology 2019;18:310-7. [DOI: 10.1016/j.aohep.2018.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 May HT, Anderson JL, Muhlestein JB, Lappé DL, Ronnow BS, Horne BD. Improvement in the predictive ability of the Intermountain Mortality Risk Score by adding routinely collected laboratory tests such as albumin, bilirubin, and white cell differential count. Clinical Chemistry and Laboratory Medicine (CCLM) 2016;54. [DOI: 10.1515/cclm-2015-1258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Ma C, Crespin M, Proulx MC, DeSilva S, Hubbard J, Prusinkiewicz M, Nguyen GC, Panaccione R, Ghosh S, Myers RP. Postoperative complications following colectomy for ulcerative colitis: a validation study. BMC Gastroenterol. 2012;12:39. [PMID: 22943760 DOI: 10.1186/1471-230x-12-39] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
7 Kulmala KA, Björk J, Andersson S, Backman AS, Eberhardson M, Bresso F, Hedin CRH. Older age is a risk factor for inadequate energy intake during acute, severe IBD and is associated with shorter time to relapse. Scand J Gastroenterol 2020;55:1185-92. [PMID: 32905738 DOI: 10.1080/00365521.2020.1818119] [Reference Citation Analysis]
8 Kruger AJ, Hinton A, Afzali A. Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients. Inflamm Bowel Dis 2019;25:894-901. [PMID: 30247551 DOI: 10.1093/ibd/izy297] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Bischoff SC, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, Shamir R, Stardelova K, Wierdsma N, Wiskin AE, Forbes A. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Clin Nutr 2020;39:632-53. [PMID: 32029281 DOI: 10.1016/j.clnu.2019.11.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 22.0] [Reference Citation Analysis]
10 Chiu E, Oleynick C, Raman M, Bielawska B. Optimizing Inpatient Nutrition Care of Adult Patients with Inflammatory Bowel Disease in the 21st Century. Nutrients 2021;13:1581. [PMID: 34065070 DOI: 10.3390/nu13051581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rocha R, Sousa UH, Reis TLM, Santana GO. Nutritional status as a predictor of hospitalization in inflammatory bowel disease: A review. World J Gastrointest Pharmacol Ther 2019; 10(2): 50-56 [PMID: 30891328 DOI: 10.4292/wjgpt.v10.i2.50] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Palchaudhuri S, Albenberg L, Lewis JD. Diet Recommendations for Hospitalized Patients With Inflammatory Bowel Disease: Better Options Than Nil Per Os. Crohns Colitis 360 2020;2:otaa059. [PMID: 33954288 DOI: 10.1093/crocol/otaa059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ford DW, Goodwin AJ, Simpson AN, Johnson E, Nadig N, Simpson KN. A Severe Sepsis Mortality Prediction Model and Score for Use With Administrative Data. Crit Care Med 2016;44:319-27. [PMID: 26496452 DOI: 10.1097/CCM.0000000000001392] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
14 Kathrani A. Dietary and Nutritional Approaches to the Management of Chronic Enteropathy in Dogs and Cats. Vet Clin North Am Small Anim Pract 2021;51:123-36. [PMID: 33131914 DOI: 10.1016/j.cvsm.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Sung SF, Hsieh CY, Kao Yang YH, Lin HJ, Chen CH, Chen YW, Hu YH. Developing a stroke severity index based on administrative data was feasible using data mining techniques. J Clin Epidemiol 2015;68:1292-300. [PMID: 25700940 DOI: 10.1016/j.jclinepi.2015.01.009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
16 Bertani L, Ribaldone DG, Bellini M, Mumolo MG, Costa F. Inflammatory Bowel Diseases: Is There a Role for Nutritional Suggestions? Nutrients 2021;13:1387. [PMID: 33924119 DOI: 10.3390/nu13041387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg. 2011;15:267-276. [PMID: 21108015 DOI: 10.1007/s11605-010-1396-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
18 Gupta N, Lustig RH, Chao C, Vittinghoff E, Andrews H, Leu CS. Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn’s disease. World J Gastroenterol 2018; 24(18): 2036-2046 [PMID: 29760546 DOI: 10.3748/wjg.v24.i18.2036] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Forbes A, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, Shamir R, Stardelova K, Wierdsma N, Wiskin AE, Bischoff SC. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr 2017;36:321-47. [PMID: 28131521 DOI: 10.1016/j.clnu.2016.12.027] [Cited by in Crossref: 254] [Cited by in F6Publishing: 210] [Article Influence: 42.3] [Reference Citation Analysis]
20 Chen G, Lissoos T, Dieyi C, Null KD. Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study. Inflamm Bowel Dis 2021;27:1177-83. [PMID: 33043982 DOI: 10.1093/ibd/izaa263] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Sandberg KC, Davis MM, Gebremariam A, Adler J. Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011. Inflamm Bowel Dis 2014;20:1754-60. [PMID: 25185689 DOI: 10.1097/MIB.0000000000000195] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Sung SF, Chen SC, Hsieh CY, Li CY, Lai EC, Hu YH. A comparison of stroke severity proxy measures for claims data research: a population-based cohort study. Pharmacoepidemiol Drug Saf 2016;25:438-43. [PMID: 26696591 DOI: 10.1002/pds.3944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
23 Ananthakrishnan AN, McGinley EL. Weekend hospitalisations and post-operative complications following urgent surgery for ulcerative colitis and Crohn's disease. Aliment Pharmacol Ther 2013;37:895-904. [PMID: 23451882 DOI: 10.1111/apt.12272] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
24 Kassam Z, Cribb Fabersunne C, Smith MB, Alm EJ, Kaplan GG, Nguyen GC, Ananthakrishnan AN. Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection. Aliment Pharmacol Ther 2016;43:725-33. [PMID: 26849527 DOI: 10.1111/apt.13546] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
25 Hill E, Nguyen NH, Qian AS, Patel S, Chen PL, Tse CS, Singh S. Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study. Dig Dis Sci 2022. [PMID: 35503486 DOI: 10.1007/s10620-022-07505-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS, Tantry BV, Thapa BR, Goswami B, Behera BN, Ye BD, Bansal D, Desai D, Pai G, Yattoo GN, Makharia G, Wijewantha HS, Venkataraman J, Shenoy KT, Dwivedi M, Sahu MK, Bajaj M, Abdullah M, Singh N, Singh N, Abraham P, Khosla R, Tandon R, Misra SP, Nijhawan S, Sinha SK, Bopana S, Krishnaswamy S, Joshi S, Singh SP, Bhatia S, Gupta S, Bhatia S, Ghoshal UC. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol. 2019;38:220-246. [PMID: 31352652 DOI: 10.1007/s12664-019-00976-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Limketkai BN, Shah SC, Hirano I, Bellaguarda E, Colombel JF. Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut 2019;68:2152-60. [PMID: 30923072 DOI: 10.1136/gutjnl-2018-318074] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
28 Obi K, Hinton A, Sobotka L, Levine E, Conwell D, Zhang C. Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations. Dig Dis Sci 2017;62:1621-7. [PMID: 28401424 DOI: 10.1007/s10620-017-4573-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Zhang C, Krishna SG, Hinton A, Arsenescu R, Levine EJ, Conwell DL. Cytomegalovirus-Related Hospitalization Is Associated With Adverse Outcomes and Increased Health-Care Resource Utilization in Inflammatory Bowel Disease. Clin Transl Gastroenterol 2016;7:e150. [PMID: 26963000 DOI: 10.1038/ctg.2016.10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
30 Choung RS, Princen F, Stockfisch TP, Torres J, Maue AC, Porter CK, Leon F, De Vroey B, Singh S, Riddle MS, Murray JA, Colombel JF; PREDICTS Study Team. Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis. Aliment Pharmacol Ther 2016;43:1300-10. [PMID: 27117843 DOI: 10.1111/apt.13641] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
31 Jiang Y, Rim DS, Rodgers B, Ahlawat S. Sarcoidosis is associated with lower risks of penetrating disease and colectomy in hospitalized patients with inflammatory bowel disease. JGH Open 2020;4:1199-206. [PMID: 33319056 DOI: 10.1002/jgh3.12423] [Reference Citation Analysis]
32 Long GH, Tatro AR, Oh YS, Reddy SR, Ananthakrishnan AN. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data. Adv Ther 2019;36:3079-95. [PMID: 31562607 DOI: 10.1007/s12325-019-01095-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
33 Rubin DT, Mulani P, Chao J, Pollack PF, Bensimon AG, Yu AP, Ghosh S. Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial. Inflamm Bowel Dis. 2012;18:818-825. [PMID: 21887727 DOI: 10.1002/ibd.21836] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]